MaaT Pharma S.A.
MAAT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €20 | €24 | €35 | €43 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €2 | €5 | €1 | €4 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €5 | €1 | €4 | €0 |
| Total Curr. Assets | €28 | €32 | €42 | €47 |
| Property Plant & Equip (Net) | €9 | €9 | €1 | €1 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €2 | €1 | €1 | €1 |
| Long-Term Investments | €0 | €0 | €0 | €0 |
| Tax Assets | €0 | €0 | -€0 | -€0 |
| Other NC Assets | €0 | €0 | €0 | €0 |
| Total NC Assets | €11 | €11 | €3 | €2 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €39 | €43 | €45 | €49 |
| Liabilities | – | – | – | – |
| Payables | €9 | €6 | €5 | €0 |
| Short-Term Debt | €2 | €3 | €3 | €1 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €1 |
| Other Curr. Liab. | €3 | €2 | €1 | €2 |
| Total Curr. Liab. | €15 | €12 | €9 | €5 |
| LT Debt | €8 | €5 | €8 | €4 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €1 | €0 | €0 | €0 |
| Total NC Liab. | €14 | €11 | €9 | €5 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €6 | €6 | €1 | €1 |
| Total Liabilities | €28 | €22 | €18 | €10 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €1 | €1 | €1 | €1 |
| Retained Earnings | -€26 | -€18 | -€12 | -€8 |
| AOCI | €0 | €0 | €0 | €0 |
| Other Equity | €0 | €0 | €0 | €0 |
| Total Equity | €10 | €20 | €27 | €40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €39 | €43 | €45 | €49 |
| Net Debt | -€10 | -€15 | -€25 | -€38 |